CNS DRUGS Journal

publication venue for

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease. 32:387-398. 2018
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease (vol 32, pg 387, 2018) 2018

category

International Standard Serial Number (ISSN)

1172-7047

Electronic International Standard Serial Number (EISSN)

1179-1934

journal abbreviation

CNS DRUGS